Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

New contraindication added to Reclast drug label

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      FDA.FDA Drug Safety Communication: New contraindication and updated warning on kidney impairment for Reclast (zoledronic acid). Internet Document: [2 pages], 30 Aug 2011. Available from: URL: http://www.fda.gov

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    New contraindication added to Reclast drug label. React. Wkly. 1368, 3 (2011). https://doi.org/10.2165/00128415-201113680-00007

    Download citation

    Keywords

    • Public Health
    • Creatinine
    • Renal Function
    • Renal Failure
    • Serum Creatinine